Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' generic pregabalin under ANDA207623 (original application), providing a generic version of pregabalin.
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Alembic Pharmaceuticals Inc.)
The FDA approved Alembic Pharmaceuticals' original ANDA for pregabalin, enabling a generic version of pregabalin to be marketed. The approva…
-
FDA approval · 2019-07-19FDA Approved: PREGABALIN — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved Amneal Pharmaceuticals NY LLC's original ANDA for pregabalin, a generic version of Lyrica, for use in the United States. Th…
-
FDA approval · 2019-05-23FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis Div of Pfizer Inc, indicating an approved modificat…
-
FDA approval · 2019-05-22FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for a generic duloxetine from Zydus Lifesciences Limited, authorizing marketing of the product.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-04-17FDA Approved: DULOXETINE — Original Application (Qingdao BAHEAL Pharmaceutical Co., Ltd.)
FDA approved a generic version of duloxetine from Qingdao BAHEAL Pharmaceutical Co., Ltd. under an Original Application (ANDA 210599). The a…
-
FDA approval · 2018-07-19FDA Approved: DULOXETINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental ANDA for a generic duloxetine product (ANDA204343). Duloxetine is indicated for major depr…
-
FDA approval · 2017-12-19FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Savella (milnacipran hydrochloride) filed by Allergan, Inc., updating the product’s regulatory s…
-
FDA approval · 2017-10-11FDA Approved: LYRICA CR — Original Application (Viatris Specialty LLC)
FDA approves LYRICA CR (pregabalin) under an Original Application for an extended-release formulation of pregabalin.
-
FDA approval · 2017-05-18FDA Approved: DULOXETINE — Original Application (Solco Healthcare US, LLC)
FDA approved Solco Healthcare US, LLC's original application for duloxetine, enabling the marketing of a generic duloxetine product.
-
FDA approval · 2017-04-06FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for duloxetine submitted by Zydus Lifesciences Limited, advancing the regulatory status of the g…
-
FDA approval · 2017-03-23FDA Approved: DULOXETINE HYDROCHLORIDE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved the original application for duloxetine hydrochloride from Macleods Pharmaceuticals Limited, authorizing a generic version of d…
-
FDA approval · 2017-01-06FDA Approved: DULOXETINE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approved an Original Application (ANDA 208706) for duloxetine from Quallent Pharmaceuticals Health LLC, establishing a generic version o…
-
FDA approval · 2017-01-04FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) from Eli Lilly and Company.
-
FDA approval · 2016-12-22FDA Approved: LYRICA — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for LYRICA (pregabalin) submitted by Parke-Davis Division of Pfizer Inc.
-
FDA approval · 2016-09-06FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Savella (milnacipran hydrochloride) submitted by Allergan, Inc.
-
FDA approval · 2016-08-03FDA Approved: DULOXETINE — Original Application (Camber Pharmaceuticals, Inc.)
The FDA approved Camber Pharmaceuticals' original application for a generic duloxetine product. Duloxetine is used to treat multiple conditi…
-
FDA approval · 2016-01-27FDA Approved: MILNACIPRAN HYDROCHLORIDE — Original Application (Breckenridge Pharmaceutical, Inc.)
FDA approved Breckenridge Pharmaceutical’s milnacipran hydrochloride as a generic product (ANDA 205071).
-
FDA approval · 2015-12-22FDA Approved: DULOXETINE DELAYED-RELEASE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)
The FDA approved Breckenridge Pharmaceutical's supplemental application for a duloxetine hydrochloride delayed-release product, granting app…
-
FDA approval · 2015-10-28FDA Approved: DULOXETINE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' original ANDA for duloxetine, allowing a generic version to be marketed. The approval covers duloxetin…
-
FDA approval · 2015-08-26FDA Approved: DULOXETINE — Original Application (Ascend Laboratories, LLC)
The FDA approved Ascend Laboratories' original application for a generic duloxetine product (ANDA 203197), establishing a generic version of…
-
FDA approval · 2015-06-17FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Savella (milnacipran hydrochloride) from Allergan, updating the product’s labeling.
-
FDA approval · 2015-01-29FDA Approved: SAVELLA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Savella (milnacipran hydrochloride) filed by Allergan, Inc., updating the product labeling.
-
FDA approval · 2014-09-26FDA Approved: DULOXETINE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application for duloxetine from Zydus Lifesciences Limited under an ANDA. The approval involves changes to the a…
-
FDA approval · 2014-06-11FDA Approved: DULOXETINE DELAYED-RELEASE — Original Application (Breckenridge Pharmaceutical, Inc.)
FDA approved Breckenridge Pharmaceutical's original generic duloxetine hydrochloride delayed-release capsules, a generic version of the anti…